Revenue From External Customers was INVO Fertility’s largest product and service line in fiscal 2025, bringing in $6.84M of $6.87M (100%).
| Product and Service | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue From External Customers | — | — | $6.45M | $6.84M | ||||
| License | — | — | — | — | ||||
| Clinic Revenue | $614.85K | $2.86M | — | — | ||||
| Domestic Licensing Distribution Fee | — | — | — | — | ||||
| License Revenue | — | — | — | — | ||||
| Domestic Physicians | — | — | — | — | ||||
| Product Revenue | — | — | — | — | ||||
| Product | $207.34K | $158.00K | — | — | ||||
| Inter Segment Revenue | — | — | $29.00K | $27.00K | ||||
| Total | $822.20K | $3.02M | $6.48M | $6.87M |
INVO Fertility brought in $6.87M from its two product and service lines in fiscal 2025, the year ended December 31, 2025. That was up 6.0% from $6.48M in fiscal 2024. Revenue From External Customers was the largest at $6.84M (99.6%), ahead of Inter Segment Revenue at $27.00K (0.4%).
INVO Fertility began breaking out Revenue From External Customers in fiscal 2024 and Inter Segment Revenue in fiscal 2024. INVO Fertility stopped reporting Clinic Revenue ($2.86M in fiscal 2023) and Product ($158.00K in fiscal 2023) as separate lines.
Fertility Clinic Services was INVO Fertility’s largest segment in fiscal 2025, bringing in $6.72M of $6.99M (96%).
| Statement Business Segments | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|
| Fertility Clinic Services | $2.86M | $6.45M | $6.72M |
| Invocell Device | $158.00K | $81.57K | $267.39K |
| Total | $3.02M | $6.53M | $6.99M |
INVO Fertility brought in $6.99M from its two segments in fiscal 2025, the year ended December 31, 2025. That was up 7.0% from $6.53M in fiscal 2024. Fertility Clinic Services was the largest at $6.72M (96.2%), ahead of Invocell Device at $267.39K (3.8%).
Compared with fiscal 2024, Invocell Device grew 227.8% to $267.39K and Fertility Clinic Services grew 4.2% to $6.72M. From fiscal 2023 to 2025, combined revenue from these segments grew from $3.02M to $6.99M, a compound annual growth rate of 52.1%. Fertility Clinic Services' share of the total rose from 94.8% to 96.2%.
INVO Fertility (IVF) reports its revenue by product and service and by statement business segments. In fiscal 2025, Revenue From External Customers was its largest product and service line, bringing in $6.84M (99.6% of the total), followed by Inter Segment Revenue at $27.00K (0.4%).
Revenue From External Customers was INVO Fertility's largest product and service line in fiscal 2025, bringing in $6.84M, or 99.6% of the $6.87M total across its two product and service lines.
Fertility Clinic Services was INVO Fertility's largest segment in fiscal 2025, bringing in $6.72M, or 96.2% of the $6.99M total across its two segments.
Invocell Device grew faster than Fertility Clinic Services in fiscal 2025, up 227.8% from $81.57K to $267.39K. Fertility Clinic Services grew 4.2% to $6.72M.
Every figure comes from INVO Fertility's annual financial filings, as reported. Each line keeps the name INVO Fertility gives it, and years follow its fiscal calendar.
INVO Fertility's revenue by product and service goes back to fiscal 2018, with figures through fiscal 2025. The latest four fiscal years are free to view, and the full history is available with a Business Quant subscription.